SCHEMBL7260323

SCHEMBL7260323

COc1ccc(C2=NNC(=O)C2)c(OC)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.48
PDE4B Q07343 4/20 0.47
PDE4A P27815 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
PDE3B Q13370 2/20 0.47
PDE3A Q14432 2/20 0.47
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
AXL P30530 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
MAPK1 P28482 2/20 0.40
PTGS2 P35354 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864133 0.75 PDE4B (0.52) PDE4BPDE4APDE4CPDE4DPDE3B
SCHEMBL3775165 0.74 PDE4B (0.76) PDE4BPDE4APDE4CPDE4DPDE3B
SCHEMBL642228 0.70 HDAC4 (0.58) KDM4EALDH1A1HPGDHDAC4HDAC2
SCHEMBL22284818 0.68 PDE3A (0.48) CRBNPDE4BPDE4APDE4CPDE4D
SCHEMBL5560822 0.68 AXL (0.61) PDE4BPDE4APDE4CPDE4DPDE3B
SCHEMBL9879241 0.68 MEN1 (0.50) PDE4BPDE4APDE4CPDE4DPDE3B
SCHEMBL9878571 0.66 AXL (0.58) PDE3BPDE3AKDM4EALDH1A1HPGD
SCHEMBL6283678 0.66 HDAC4 (0.44) CRBNKDM4EALDH1A1HPGDHDAC4
SCHEMBL30701949 0.65 CA9 (0.50) KDM4EALDH1A1HPGDCYP3A4ACHE
SCHEMBL3674074 0.65 CA9 (0.50) KDM4EALDH1A1HPGDCYP3A4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003011287-A1 PYRAZOLON DERIVATIVES AS INHIBITORS OF GSK-3 VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-02-13 WO disclosed